105 related articles for article (PubMed ID: 22813447)
21. Promoter methylation status of multiple genes in uveal melanoma.
Merhavi E; Cohen Y; Avraham BC; Frenkel S; Chowers I; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4403-6. PubMed ID: 17898258
[TBL] [Abstract][Full Text] [Related]
22. DNA index and S phase fraction in uveal malignant melanomas.
Hodge WG; Duclos AJ; Rocha G; Antecka E; Baines MG; Corriveau C; Brownstein S; Deschenes J
Br J Ophthalmol; 1995 Jun; 79(6):521-6. PubMed ID: 7626566
[TBL] [Abstract][Full Text] [Related]
23. Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo.
Notting I; Buijs J; Mintardjo R; van der Horst G; Vukicevic S; Lowik C; Schalij-Delfos N; Keunen J; van der Pluijm G
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4882-9. PubMed ID: 17962434
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic inactivation of RASSF1a in uveal melanoma.
Maat W; van der Velden PA; Out-Luiting C; Plug M; Dirks-Mulder A; Jager MJ; Gruis NA
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):486-90. PubMed ID: 17251440
[TBL] [Abstract][Full Text] [Related]
25. Estimation of DNA content in uveal melanomas by flow cytometry.
Rennie IG; Rees RC; Parsons MA; Lawry J; Cottam D
Eye (Lond); 1989; 3 ( Pt 5)():611-7. PubMed ID: 2630338
[TBL] [Abstract][Full Text] [Related]
26. Prediction of metastasis of uveal melanoma: comparison of morphometric determination of nucleolar size and spectrophotometric determination of DNA.
McLean IW; Gamel JW
Invest Ophthalmol Vis Sci; 1988 Apr; 29(4):507-11. PubMed ID: 3356509
[TBL] [Abstract][Full Text] [Related]
27. Altered chromosome expression of uveal melanoma in the setting of melanocytosis.
Horgan N; Shields CL; Swanson L; Teixeira LF; Eagle RC; Ganguly A; Shields JA
Acta Ophthalmol; 2009 Aug; 87(5):578-80. PubMed ID: 18547285
[No Abstract] [Full Text] [Related]
28. Prognostic parameters in uveal melanoma: a review.
Mooy CM; De Jong PT
Surv Ophthalmol; 1996; 41(3):215-28. PubMed ID: 8970236
[TBL] [Abstract][Full Text] [Related]
29. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
[TBL] [Abstract][Full Text] [Related]
30. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
[TBL] [Abstract][Full Text] [Related]
31. Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma.
Bronkhorst IH; Maat W; Jordanova ES; Kroes WG; Schalij-Delfos NE; Luyten GP; Jager MJ
Arch Pathol Lab Med; 2011 Aug; 135(8):1042-7. PubMed ID: 21809997
[TBL] [Abstract][Full Text] [Related]
32. Pathology and genetics of uveal melanoma.
Griewank KG; Murali R
Pathology; 2013 Jan; 45(1):18-27. PubMed ID: 23222249
[TBL] [Abstract][Full Text] [Related]
33. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
[TBL] [Abstract][Full Text] [Related]
34. Mouse pigmentation mutants help identify a uveal melanoma oncogene.
Hayward NK
Pigment Cell Melanoma Res; 2009 Feb; 22(1):2-3. PubMed ID: 19140886
[No Abstract] [Full Text] [Related]
35. Analysis of GNAQ mutations, proliferation and MAPK pathway activation in uveal melanomas.
Pópulo H; Vinagre J; Lopes JM; Soares P
Br J Ophthalmol; 2011 May; 95(5):715-9. PubMed ID: 20805136
[TBL] [Abstract][Full Text] [Related]
36. The relationships between p53 protein expression and the clinicopathological features in the uveal melanomas.
Hussein MR
Cancer Biol Ther; 2005 Jan; 4(1):57-9. PubMed ID: 15662123
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of chemokine receptors on uveal melanoma cells and their metastases.
Li H; Alizadeh H; Niederkorn JY
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):636-43. PubMed ID: 18235009
[TBL] [Abstract][Full Text] [Related]
38. Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma.
Vaarwater J; van den Bosch T; Mensink HW; van Kempen C; Verdijk RM; Naus NC; Paridaens D; Brüggenwirth HT; Kiliç E; de Klein A
Melanoma Res; 2012 Feb; 22(1):30-7. PubMed ID: 22157614
[TBL] [Abstract][Full Text] [Related]
39. [Cellular type of uveal melanoblastomas of the eye and the nuclear DNA content (a cytophotometric study)].
Vit VV
Oftalmol Zh; 1982; 37(8):502-7. PubMed ID: 7162748
[No Abstract] [Full Text] [Related]
40. Flow cytometry of uveal melanomas.
Shapiro BE; Felberg NT; Donoso LA; Augsburger JJ; Shields JA; Gamel J
Cancer Biochem Biophys; 1986 Jul; 8(3):235-8. PubMed ID: 3742483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
